A 79-year-old man on continuous ambulatory peritoneal dialysis (CAPD) developed abdominal pain and cloudy peritoneal fluid two days after colonoscopy that revealed multiple diverticula. The white blood cell count was 9,000 cells/μL, C-reactive protein level was 6.86 mg/dL, and the white blood cell count of the peritoneal fluid was 7,800 cells/μL, suggesting acute peritonitis. Empiric therapy consisting of cefazolin and ceftazidime slowly improved the patient's symptoms. The initial microbiological examination of the peritoneal fluid demonstrated Morganella morganii. He was changed from CAPD to hemodialysis. It is important to consider M. morganii peritonitis in patients with colonic diverticula.
Introduction
Morganella morganii is a Gram-negative rod commonly found as normal flora in the intestinal tracts of humans, mammals, and reptiles or as environmental bacteria. Initially, M. morganii had been classified in the Proteus genus, and had been called Proteus morganii. In 1978, it was reclassified into the Morganella genus (1) . A cluster of M. morganii infections occurred at a general tertiary hospital in 2006 (2) , consisting of 61% wound infections and 39% urinary tract infections. M. morganii has been reported as the cause of urinary tract infections (3), arthritis (4), pericarditis (5), pyomyositis (6) , sepsis (7), chorioamnionitis (8) , ecthyma gangrenosum-like eruptions (9) , meningitis (10), renal abscesses (11), and gas gangrene (12) in neonates or elderly immunocompromised patients or those with other serious underlying diseases.
M. morganii infections generally respond well to appropriate antimicrobial chemotherapy. However, its natural resistance to many β-lactam antimicrobial agents may lead to delays in proper treatment (13) . We herein report a case of peritonitis due to M. morganii related to CAPD after colonoscopy with a review of the pertinent literature.
Case Report
A 79-year-old Japanese man was admitted to the Division of Nephrology and Rheumatology at Aichi Medical University Hospital for a fever, abdominal pain, and cloudy peritoneal fluid. Thirty years prior to admission, he was diagnosed with hypertension. One year before admission, CAPD was initiated for end-stage kidney disease. His regular peritoneal dialysis routine consisted of four exchanges of 1.5 L bags of 1.5% glucose solution. His daily urine output ranged from 400 to 1,200 mL. Two days before admission, he underwent colonoscopy for an evaluation of diarrhea. Multiple diverticula were observed in the colon, and a diagnosis of diverticulosis was made (Figure) . No pathologic organisms were detected. On the day of colonoscopy, he stopped peritoneal dialysis to empty and rest the peritoneal cavity. Several hours after the resumption of peritoneal dialysis, he developed abdominal pain with cloudy peritoneal fluid.
On admission, he was afebrile at 36.5 and complained On hospital day 5, after cefazolin (1.0 g/day) and ceftazidime (1.0 g/day) were started empirically, the WBC count of the peritoneal fluid became 51 cells/μL, and the CRP level was 2.0 mg/dL. The initial peritoneal fluid bacterial culture grew out Morganella morganii resistant to cefotiam (CTM), sultamicillin (SBTPC), and fosfomycin (FOM), and sensitive to third-generation cephalosporins such as cefcapene pivoxil (CFPN-PI), ceftazidime (CAZ), and cefpodoxime proxetil (CPDX-PR). We continued CAZ for 16 days and discontinued cefazolin. The patient's clinical condition and laboratory data improved gradually. He was changed from CAPD to hemodialysis due to the risk of bacterial biofilm formation and recurrence of peritonitis due to multiple diverticulosis.
Discussion
Morganella morganii is a Gram-negative rod that is part of the normal flora of the intestinal tract in humans and other animals. Characteristics of this organism include indole production, ornithine decarboxylase, urease, phenylalanine deaminase, and growth in KCN (1). In addition, Morganella species are capable of producing β-lactamases (13). Initially, M. morganii was mainly identified as a cause of urinary tract infections (3), and it has subsequently been isolated in patients with pneumonia, wound infections, skin and soft tissue infections (2), nonclostridial gas gangrene (12), meningitis (10), and sepsis (7). Falagas et al. reported 24 patients infected with M. morganii over a four-year period in a general tertiary hospital in Greece with 650 beds (2). They noted that skin and soft tissue infections were the most common type of infections due to M. morganii. Only one patient had peritonitis secondary to appendicitis, and 58% of the patients in that series had polymicrobacterial infections. They also commented that 70% and 96% of isolated M. morganii were resistant to ceftriaxone, and amoxicillin/clavulanic acid, respectively. Chen et al. performed whole genome sequencing and identification of M. morganii (14) . Out of 82,861 samples they examined, M. morganii was isolated in 1,219 samples (1.47%) during a six-year period (2006) (2007) (2008) (2009) (2010) (2011) in Taiwan. They found novel characteristics of M. morganii through an analysis of pathogenicity-related genes. In the present patient, M. morganii was resistant to cefazolin but sensitive to ceftazidime.
Regarding peritonitis due to M. morganii, Isobe et al. first reported a patient with spontaneous bacterial emphysema and peritonitis in 1994 (15) . The second case was part of a case series by Falagas et al. (2) . The first case of CAPDrelated peritonitis caused by M. morganii appeared in Turkey in 2010 (16) . The second case occurred in Taiwan (17) and the third case was in Austria (18) . The present case is the fourth such case so far reported in the literature (Table) .
We changed the patient from CAPD to hemodialysis due to the risk of bacterial biofilm formation by M. morganii and multiple diverticulosis. M. morganii produces urease, which generates ammonia from urea, and is associated with crystalline bacterial biofilm formation on urinary catheters (19) . It is able to survive in acidic conditions, and the urease it produces is activated in low pH environments. In addition, the present patient had multiple diverticula, which (20) . In Europe and the United States, 30-40% of individuals over 60 years of age have diverticulosis, and the incidence increases with age. In Japan, the incidence of diverticulosis is approximately 20% in individuals over 60 years of age, compared to 5% in individuals younger than 40 years of age. This is the first reported case of peritonitis caused by M. morganii after colonoscopy. If patients have multiple diverticula, colonoscopy may induce bacterial peritonitis, sometimes M. morganii-related peritonitis. In the present case, we did not use antibiotics before colonoscopy. When we have to perform colonoscopy in patients on CAPD, cefditoren pivoxil, cefixime, levofloxacin, or norfloxacin is recommended as prophylactic antibiotics. Extreme care should therefore be taken during colonoscopy, especially in patients on CAPD.
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